Answers are grounded in this paper and cite their sources.
We describe the case of an 87‐year‐old gentleman referred to a metropolitan hospital in Sydney with pneumomediastinum complicating immunotherapy associated pneumonitis and recent bronchoscopic intervention. The contribution of pneumonitis in the setting of interstitial lung disease has been well described to developing pneumomediastinum however this is less clear in the setting of immunotherapy associated pneumonitis and to what extent bronchoscopic intervention compounds this risk.
No takes yet. Share an insight, caveat, or question.
Carrozzi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: